These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30558903)

  • 1. The role of genetic testing in dyslipidaemia.
    Berberich AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):184-192. PubMed ID: 30558903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disorders.
    Berberich AJ; Hegele RA
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101719. PubMed ID: 36641373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An abnormal lipid profile: when to perform additional research for a genetic cause?].
    Heidemann BE; Prinssen M; Marais AD; Visseren FLJ; Koopal C
    Ned Tijdschr Geneeskd; 2022 Nov; 166():. PubMed ID: 36633039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can genetic testing help in the management of dyslipidaemias?
    Lazarte J; Hegele RA
    Curr Opin Lipidol; 2020 Aug; 31(4):187-193. PubMed ID: 32520779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brave new world of genetic testing in the management of the dyslipidaemias.
    Nawawi HM; Chua YA; Watts GF
    Curr Opin Cardiol; 2020 May; 35(3):226-233. PubMed ID: 32097179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
    Brown EE; Sturm AC; Cuchel M; Braun LT; Duell PB; Underberg JA; Jacobson TA; Hegele RA
    J Clin Lipidol; 2020; 14(4):398-413. PubMed ID: 32507592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in genetic testing for familial hypercholesterolemia.
    Iacocca MA; Hegele RA
    Expert Rev Mol Diagn; 2017 Jul; 17(7):641-651. PubMed ID: 28524730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
    Hooper AJ; Burnett JR; Bell DA; Watts GF
    Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
    Wang J; Dron JS; Ban MR; Robinson JF; McIntyre AD; Alazzam M; Zhao PJ; Dilliott AA; Cao H; Huff MW; Rhainds D; Low-Kam C; Dubé MP; Lettre G; Tardif JC; Hegele RA
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2439-2445. PubMed ID: 27765764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of familial hypercholesterolaemia.
    Graham CA; Latten MJ; Hart PJ
    Curr Opin Lipidol; 2017 Aug; 28(4):313-320. PubMed ID: 28463860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of DNA copy number variation in dyslipidemias.
    Iacocca MA; Hegele RA
    Curr Opin Lipidol; 2018 Apr; 29(2):125-132. PubMed ID: 29303791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia.
    Correia M; Kagenaar E; van Schalkwijk DB; Bourbon M; Gama-Carvalho M
    Sci Rep; 2021 Feb; 11(1):3801. PubMed ID: 33589716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice.
    Garg A; Garg V; Hegele RA; Lewis GF
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):880-886. PubMed ID: 31445954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
    Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
    Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine.
    Peterlin A; Petrovič D; Peterlin B
    Curr Vasc Pharmacol; 2019; 17(1):25-28. PubMed ID: 29412113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
    Pears R; Griffin M; Futema M; Humphries SE
    Curr Opin Lipidol; 2015 Jun; 26(3):162-8. PubMed ID: 25887683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicronaemia--current diagnosis and future therapies.
    Brahm AJ; Hegele RA
    Nat Rev Endocrinol; 2015 Jun; 11(6):352-62. PubMed ID: 25732519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.